Traitements2programmes
Essais1liés
Publications3liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
B001It's the first-in-human study of Recombinant Humanized Anti-CD20 Monoclonal Antibody for Injection (B001). The main purpose of this study is to explore the safety and tolerance of B001 for patients with CD20 positive B-cell non Hodgkin's lymphoma. It will also explore the PK/PD manner and ORR in this study. SEP Phase 1 Immunomodulation China À vérifier
B001It's the first-in-human study of Recombinant Humanized Anti-CD20 Monoclonal Antibody for Injection (B001). The main purpose of this study is to explore the safety and tolerance of B001 for patients with CD20 positive B-cell non Hodgkin's lymphoma. It will also explore the PK/PD manner and ORR in this study. SEP Phase 1 Immunomodulation China À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
B001 SEP Phase 1 NCT03332121 B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma COMPLETED

Publications

3
MoléculeIndication / populationTitreJournalDate
B001 BoOFP6 Negatively Regulates Glucosinolates Accumulation in Broccoli Sprouts by Cytoplasmic Sequestration of BoMYB34-3. Plant, cell & environment
B001 Robot‑assisted versus open radical nephrectomy and venous tumor thrombectomy: perioperative and oncologic outcomes-an inverse probability of treatment weighting analysis. Surgical endoscopy
B001 Centrosome migration and apical membrane formation during epithelial polarization in MDCK cysts. eLife